Elsa Bou Ghanem

Dr. Elsa Bou Ghanem

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2021 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
SSShaunna R. Simmons
Shaunna R. Simmons
MBManmeet Bhalla
Manmeet Bhalla
SHSydney E. Herring
Sydney E. Herring
ETEssi Y. I. Tchalla
Essi Y. I. Tchalla
EGElsa Bou Ghanem
Elsa Bou Ghanem
Elderly individuals are at increased risk of life-threatening pulmonary infections. Neutrophils are a key determinant of the disease course of pathogen-induced pneumonia.

14 November 2022 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SHSydney E. Herring
Sydney E. Herring
SMSovathiro Mao
Sovathiro Mao
MBManmeet Bhalla
Manmeet Bhalla
ETEssi Y. I. Tchalla
Essi Y. I. Tchalla
JKJill M. Kramer
Jill M. Kramer
EGElsa Bou Ghanem
Elsa Bou Ghanem
Polymorphonuclear cells (PMNs) controlStreptococcus pneumoniae(pneumococcus) infection through various antimicrobial activities. We previously found that reactive oxygen species (ROS) were required for optimal antibacterial function, however, the NADPH oxidase is known to be dispensable for the ability of PMNs to kill pneumococci. In this study, we explored the role of ROS produced by the mitochondria in PMN antimicrobial defense against pneumococci. We found that the mitochondria are an important source of overall intracellular ROS produced by murine PMNs in response to infection. We investigated the host and bacterial factors involved and found that mitochondrial ROS (MitROS) are produced independent of bacterial capsule or pneumolysin but presence of live bacteria that are in direct contact with PMNs enhanced the response. We further found that MyD88-/-PMNs produced less MitROS in response to pneumococcal infection suggesting that released bacterial products acting as TLR ligands are sufficient for inducing MitROS production in PMNs. To test the role of MitROS in PMN function, we used an opsonophagocytic killing assay and found that MitROS were required for the ability of PMNs to kill pneumococci. We then investigated the role of MitROS in host resistance and found that MitROS are produced by PMNs in response to pneumococcal infection. Importantly, treatment of mice with a MitROS scavenger prior to systemic challenge resulted in reduced survival of infected hosts. In exploring host pathways that control MitROS, we focused on extracellular adenosine, which is known to control PMN anti-pneumococcal activity, and found that signaling through the A2B adenosine receptor inhibits MitROS production by PMNs. A2BR-/-mice produced more MitROS and were significantly more resistant to infection. Finally, we verified the clinical relevance of our findings using human PMNs. In summary, we identified a novel pathway that controls MitROS production by PMNs, shaping host resistance againstS.pneumoniae.

4 February 2020 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
NSNalat Siwapornchai
Nalat Siwapornchai
JLJames N. Lee
James N. Lee
ETEssi Y I Tchalla
Essi Y I Tchalla
MBManmeet Bhalla
Manmeet Bhalla
JYJun Hui Yeoh
Jun Hui Yeoh
EGElsa Bou Ghanem
Elsa Bou Ghanem

13 August 2020 in Aging Cell
Verified
Journal Article
Open access
PDF file
MBManmeet Bhalla
Manmeet Bhalla
SSShaunna R. Simmons
Shaunna R. Simmons
AAAlexsandra Abamonte
Alexsandra Abamonte
SHSydney E. Herring
Sydney E. Herring
SRSara E. Roggensack
Sara E. Roggensack
EGElsa Bou Ghanem
Elsa Bou Ghanem
Summary: The elderly are susceptible to serious infections by Streptococcus pneumoniae (pneumococcus), which calls for a better understanding of the pathways driving the decline in host defense in aging. We previously found that extracellular adenosine (EAD) shaped polymorphonuclear cell (PMN) responses, which are crucial for controlling infection. EAD is produced by CD39 and CD73, and signals via A1, A2A, A2B, and A3 receptors. The objective of this study was to explore the age‐driven changes in the EAD pathway and its impact on PMN function. We found in comparison to young mice, PMNs from old mice expressed significantly less CD73, but similar levels of CD39 and adenosine receptors. PMNs from old mice failed to efficiently kill pneumococci ex vivo; however, supplementation with adenosine rescued this defect. Importantly, transfer of PMNs expressing CD73 from young mice reversed the susceptibility of old mice to pneumococcal infection. To identify which adenosine receptor(s) is involved, we used specific agonists and inhibitors. We found that A1 receptor signaling was crucial for PMN function as inhibition or genetic ablation of A1 impaired the ability of PMNs from young mice to kill pneumococci. Importantly, activation of A1 receptors rescued the age‐associated defect in PMN function. In exploring mechanisms, we found that PMNs from old mice failed to efficiently kill engulfed pneumococci and that A1 receptor controlled intracellular killing. In summary, targeting the EAD pathway reverses the age‐driven decline in PMN antimicrobial function, which has serious implications in combating infections.

23 March 2022 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
SSShaunna R. Simmons
Shaunna R. Simmons
ETEssi Y. I. Tchalla
Essi Y. I. Tchalla
MBManmeet Bhalla
Manmeet Bhalla
EGElsa Bou Ghanem
Elsa Bou Ghanem
Despite the availability of vaccines, Streptococcus pneumoniae (pneumococcus) remains a serious cause of infections in the elderly. The efficacy of anti-pneumococcal vaccines declines with age. While age-driven changes in antibody responses are well defined, less is known about the role of innate immune cells such as polymorphonuclear leukocytes (PMNs) in the reduced vaccine protection seen in aging. Here we explored the role of PMNs in protection against S. pneumoniae in vaccinated hosts. We found that depletion of PMNs in pneumococcal conjugate vaccine (PCV) treated young mice prior to pulmonary challenge with S. pneumoniae resulted in dramatic loss of host protection against infection. Immunization boosted the ability of PMNs to kill S. pneumoniae and this was dependent on bacterial opsonization by antibodies. Bacterial opsonization with immune sera increased several PMN anti-microbial activities including bacterial uptake, degranulation and ROS production. As expected, PCV failed to protect old mice against S. pneumoniae. In probing the role of PMNs in this impaired protection, we found that aging was accompanied by an intrinsic decline in PMN function. PMNs from old mice failed to effectively kill S. pneumoniae even when the bacteria were opsonized with immune sera from young controls. In exploring mechanisms, we found that PMNs from old mice produced less of the antimicrobial peptide CRAMP and failed to efficiently kill engulfed pneumococci. Importantly, adoptive transfer of PMNs from young mice reversed the susceptibility of vaccinated old mice to pneumococcal infection. Overall, this study demonstrates that the age-driven decline in PMN function impairs vaccine-mediated protection against Streptococcus pneumoniae.

10 November 2019 in Cellular Microbiology
Verified
Journal Article
Closed access
PDF file
MBManmeet Bhalla
Manmeet Bhalla
JYJun Hui Yeoh
Jun Hui Yeoh
CLClaire Lamneck
Claire Lamneck
SHSydney E. Herring
Sydney E. Herring
ETEssi Y.I. Tchalla
Essi Y.I. Tchalla
EGElsa Bou Ghanem
Elsa Bou Ghanem